These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 22079263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.
    Tsirigotis P, Kaloyannidis P, Papalexandri A, Baltadakis I, Karakasis D, Batsis I, Sakellari I, Kitra V, Goussetis E, Papageorgiou S, Spyridonidis A, Graphakos S, Harhalakis N, Dervenoulas I, Anagnostopoulos A.
    Transfus Apher Sci; 2012 Apr; 46(2):173-80. PubMed ID: 22036202
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
    Rutella S, Valentini CG, Ceccarelli S, Romano MT, Brescia LP, Milano GM, Locatelli F.
    Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
    [Abstract] [Full Text] [Related]

  • 9. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, Evrard B, Berger C, Stephan JL, Galambrun C, Piguet C, D'Incan M, Bordigoni P, Deméocq F.
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [Abstract] [Full Text] [Related]

  • 10. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT, Ibatici A, Lamparelli T, Bruno B, Raiola AM, Dominietto A, Di Grazia C, Bregante S, Zia S, Ferrari GM, Stura P, Pogliani E, Bacigalupo A.
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [Abstract] [Full Text] [Related]

  • 11. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients.
    Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Deméocq F.
    Transfus Apher Sci; 2003 Feb; 28(1):71-80. PubMed ID: 12620271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J, Taylor P.
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [Abstract] [Full Text] [Related]

  • 16. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR.
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F, Claise C.
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [Abstract] [Full Text] [Related]

  • 20. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes.
    Bladon J, Taylor PC.
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):293-302. PubMed ID: 16313240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.